Abstract:Background/Aims: PITX1 has been identified as a potential tumor-suppressor gene in several malignant tumors. The molecular mechanism underlying PITX1, particularly its function as a transcription factor regulating gene expression during tumorigenesis, is still poorly understood. Methods: The expression level and location of PITX1 were determined by quantitative reverse transcription PCR (qRT-PCR) and immunohistochemical staining in gastric cancer (GC). The effect of PITX1 on the GC cell proliferation and tumorigenesis was analyzed in vitro and in vivo. To explore how PITX1 suppresses cell proliferation, we used PITX1-ChIP-sequencing to measure genome-wide binding sites of PITX1 and assessed global function associations based on its putative target genes. ChIP-PCR, electrophoretic mobility shift assay, and promoter reporter assays examined whether PITX1 bound to PDCD5 and regulated its expression. The function of PDCD5 in GC cell apoptosis was further examined in vitro and in vivo. The relationship between the PITX1 protein level and GC patient prognosis was evaluated by the Kaplan-Meier estimator. Meanwhile, the expression level of miR-19a-3p, which is related to PITX1, was also detected by luciferase reporter assay, qRT-PCR, and western blotting. Results: The expression level of PITX1 was decreased in GC tissues and cell lines. Elevated PITX1 expression significantly suppressed the cell proliferation of GC cells and tumorigenesis in vitro and in vivo. PITX1 knockdown blocked its inhibition of GC cell proliferation. PITX1 bound to whole genome-wide sites, with these targets enriched on genes with functions mainly related to cell growth and apoptosis. PITX1 bound to PDCD5, an apoptosis-related gene, during tumorigenesis, and cis-regulated PDCD5 expression. Increased PDCD5 expression in GC cells not only induced GC cell apoptosis, but also suppressed GC cell growth in vitro and in vivo. Moreover, PITX1 expression was regulated by miR-19a-3p. More importantly, a decreased level of PITX1 protein was correlated with poor GC patient prognosis. Conclusion: Decreased expression of PITX1 predicts shorter overall survival in GC patients. As a transcriptional activator, PITX1 regulates apoptosis-related genes, including PDCD5, during gastric carcinogenesis. These data indicate PDCD5 to be a novel and feasible therapeutic target for GC.

High Expression of Pituitary Tumor Gene Family is a Predictor for Poor Prognosis of Gastric Cancer

PTTG3P Promotes Gastric Tumour Cell Proliferation and Invasion and is an Indicator of Poor Prognosis.

Expression of Pituitary Tumor Transforming Gene in Human Gastric Carcinoma

High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer.

Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer

Bioinformatics Insight Into Glycosyltransferase Gene Expression In Gastric Cancer: Pofut1 Is A Potential Biomarker

The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma

The expression of pituitary tumor transforming gene (PTTG) in breast cancer and its clinical significance

Mir-338-3p Functions As a Tumor Suppressor in Gastric Cancer by Targeting PTP1B

Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients

PTPN14 Promotes Gastric Cancer Progression by PI3KA/AKT/mTOR Pathway

Expression of PTPN13 in human gastric cancer and gastric cancer SGC-7901 cell line and its effect on cell proliferation and invasion

Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5

Pituitary Tumor Transforming Gene-1 in Non-Small Cell Lung Cancer: Clinicopathological and Immunohistochemical Analysis

Significance of Pituitary Tumor Transforming Gene 1 (PTTG1) in Prostate Cancer.

The Clinical Significance and Potential Molecular Mechanism of PTTG1 in Esophageal Squamous Cell Carcinoma

Expression of Protein Tyrosine Phosphatase 1B and Its Clinical Significance in Gastric Cancer

Study on the expression of pituitary tumor-transforming(PTTG) and fragile histidine triad(FHIT) in gastric cancer and pericancerous tissues

Pttg Overexpression Promotes Lymph Node Metastasis In Human Esophageal Squamous Cell Carcinoma

A Comprehensive Pan-Cancer Analysis for Pituitary Tumor-Transforming Gene 1

Frequent Amplification of PTP1B is Associated with Poor Survival of Gastric Cancer Patients.